Searched for
TENTATIVE NOD
Alembic Pharma gets USFDA tentative nod for generic prostate cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate c...- Lupin gets tentative nod from USFDA for generic Sugammadex injectionLupin Ltd, a prominent name in the pharmaceutical world, revealed on Tuesday that it has gained tentative approval from the US health autho...
- Lupin gains 1% on tentative USFDA nod to generic BrexpiprazoleAt 09:30 hours (IST), Lupin’s shares traded at Rs 957.70 on the National Stock Exchange, up 1.11% from previous close.
- Lupin gets tentative nod from USFDA to market generic Brexpiprazole tabletsThe company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Brexpiprazole tab...
- Lupin gets tentative nod from USFDA for its toenail fungus treatment topical solutionThe company has received tentative approval to market its Efinaconazole topical solution, 10%, from the United States Food and Drug Adminis...
- Alembic Pharma's JV Aleor Dermaceuticals gets tentative nod from USFDA for testosterone gelAleor Dermaceuticals has received tentative approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug applicat...
- Zydus Cadila gets tentative nod from USFDA to market Parkinson's disease drugThe company has received tentative approval from the United States Food and Drug Administration (USFDA) to market the capsules in the stren...
- Glenmark gets tentative nod from USFDA for generic multiple sclerosis treatment drugThese are generic version of Tecfidera Capsules, 120 mg and 240 mg, of Biogen Inc.
- Zydus Cadila gets USFDA's tentative nod for Deferasirox tabletsThe group now has 202 approvals and has so far filed over 330 abbreviated new drug applications (ANDAs) since the commencement of the filin...
- Glenmark gets USFDA's tentative nod for Saxagliptin tabletsAccording to IMS Health sales data for the 12-month period ending April 2017, the Onglyza tablets, 2.5 mg and 5 mg market achieved annual s...
- Glenmark gets USFDA tentative nod for oral contraceptivesAccording to IMS Health sales data for the 12 months to February 2016, Lo Loestrin Fe achieved annual sales of around $432.2 million, Glenm...
- Zydus Cadila gets tentative USFDA nod for cancer cureDrug firm Zydus Cadila has received tentative nod from the US health regulator to market Clofarabine injection, used for treatment of cancer
- Glenmark gets tentative nod from USFDA for azelaic acid gelCiting IMS Health sales data, the company said the Finacea market achieved annual sales of approximately USD 128 million.
- Aurobindo Pharma climbs about 2% on tentative USFDA nod for generic drugReacting to the development, the scrip gained 1.46 per cent to hit a high of Rs 885 on BSE.
- Zydus gets USFDA tentative nod to market anti-diabetic tablets"The group now has 97 approvals and has so far filed 249 ANDAs since the commencement of the filing process in 2003-2004."
- Wockhardt gets USFDA tentative nod for generic rhinitis drugPharmaceutical and biotechnology firm Wockhardt today said it has received tentative approval from USFDA to sell generic version of Sanofi ...
- Glenmark gets USFDA's tentative nod for RiluzoneGlenmark Generics, a subsidiary of Glenmark Pharmaceuticals, today said it has received tentative approval from the USFDA for generic versi...
- Aurobindo gets USFDA's tentative nod for CrestorAurobindo Pharma said it has received tentative approval of the USFDA for the generic version of Crestor tablets used in the cardiovascular...
- Ranbaxy gets USFDA approval for anti-allergic drugRanbaxy Laboratories on Friday said its US subsidiary Ranbaxy Pharmaceuticals Inc (RPI) has received tentative nod from United States Food ...
- RPI gets USFDA tentative nod for anti-allergic drugRanbaxy Laboratories on Friday said its US subsidiary Ranbaxy Pharmaceuticals Inc (RPI) has received tentative nod from United States Food ...
Load More
